Washington, DC — According to state and local economic development sources Novo Nordisk plans to invest $1,763,900.00 to build out 7,804 square feet of new space in Washington. The company plans to occupy the new space at 1000 F St NW 4th Floor in Washington, on or about June 1, 2021. According to the company website For almost 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems. Our treatments today are helping millions of people living with diabetes, obesity, rare bleeding disorders, and growth hormone-related disorders. From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. We focus on serious chronic diseases affecting millions of Americans who are among our world’s most urgent health challenges. By combining our innovation and commercial excellence, we draw upon insights from patients and partners to transform bold ideas into life-saving medicines.

To learn more about Novo Nordisk, visit http://www.novonordisk-us.com/

Company Contact:
Doug Langa, President
https://www.linkedin.com/in/douglanga/
609-987-5800

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved